FDA — authorised 31 December 1990
- Marketing authorisation holder: FERA PHARMS
- Status: approved
FDA authorised Dapiprazole Hydrochloride on 31 December 1990
Same drug, different regulators. Each page below lists the local marketing authorisation, HTA position, pricing, and adverse-event data.
Yes. FDA authorised it on 31 December 1990.
FERA PHARMS holds the US marketing authorisation.